Clinical Trial Update: The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary Tract Malignant Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Benmelstobart Injection for advanced biliary tract cancers and the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Benmelstobart Injection (Benmelstobart)

Snippet

Sponsor: The Second Affiliated Hospital of Shandong First Medical University | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING